oleanolic acid 3-o-monoglucuronide has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Dou, X; Guo, J; Le, Y; Liu, J; Liu, Y; Liu, Z; Lu, D; Qiu, J; Wang, C | 1 |
1 other study(ies) available for oleanolic acid 3-o-monoglucuronide and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway.
Topics: Animals; Diet, High-Fat; Inflammasomes; Inflammation; Lipids; Liver; Mice; Non-alcoholic Fatty Liver Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyroptosis; Saponins | 2024 |